IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,883,763 | -23.3% | 633,794 | +18.7% | 0.03% | +3.0% |
| Q2 2023 | $3,760,472 | -8.5% | 534,158 | -20.6% | 0.03% | -17.5% |
| Q1 2023 | $4,111,346 | +13.6% | 672,888 | +18.8% | 0.04% | +5.3% |
| Q4 2022 | $3,620,395 | -99.9% | 566,572 | -4.9% | 0.04% | -38.7% |
| Q3 2022 | $5,705,963,000 | +75425.7% | 595,612 | -13.0% | 0.06% | -17.3% |
| Q2 2022 | $7,555,000 | -15.3% | 684,333 | +27.7% | 0.08% | +8.7% |
| Q1 2022 | $8,921,000 | -56.2% | 535,770 | -49.8% | 0.07% | -8.0% |
| Q4 2021 | $20,390,000 | +1140.3% | 1,068,072 | +1502.0% | 0.08% | +341.2% |
| Q3 2021 | $1,644,000 | +6.9% | 66,672 | +12.8% | 0.02% | 0.0% |
| Q2 2021 | $1,538,000 | +176.1% | 59,120 | +236.0% | 0.02% | +142.9% |
| Q1 2021 | $557,000 | – | 17,597 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |